Drug Information

Drug General Information
Drug ID
D05TKB
Former ID
DCL001190
Drug Name
GS-9256
Drug Type
Small molecular drug
Indication HCV infection [ICD9: 070.4, 070.5, 070.70; ICD10:B17.1, B18.2] Phase 2 [550812]
Company
Gilead
Structure
Download
2D MOL

3D MOL
Formula
C46H56ClF2N6O8PS
Canonical SMILES
CC(C)NC1=NC(=CS1)C2=NC3=C(C=CC(=C3Cl)OC)C(=C2)OC4CC5C(=<br />O)NC6(CC6CCCCCCCC(C(=O)N5C4)NC(=O)OC7CCCC7)P(=O)(CC8=C(<br />C=CC=C8F)F)O
InChI
1S/C46H56ClF2N6O8PS/c1-26(2)50-44-52-36(25-65-44)35-21-39(30-18-19-38(61-3)40(47)41(30)51-35)62-29-20-37-42(56)54-46(64(59,60)24-31-32(48)15-11-16-33(31)49)22-27(46)12-7-5-4-6-8-17-34(43(57)55(37)23-29)53-45(58)63-28-13-9-10-14-28/h11,15-16,18-19,21,25-29,34,37H,4-10,12-14,17,20,22-24H2,1-3H3,(H,50,52)(H,53,58)(H,54,56)(H,59,60)/t27-,29-,34+,37+,46+/m1/s1
InChIKey
RFGUWOCFYCYEDM-ZOMNBDOOSA-N
PubChem Compound ID
24823649
PubChem Substance ID
49839772, 57134086, 136932459, 162108907, 198979069, 223714515, 235332666, 246195701
Target and Pathway
Target(s) HIV protease Target Info Inhibitor [550812]
References
Ref 550812Clinical pipeline report, company report or official report of Gilead (2011).
Ref 550812Clinical pipeline report, company report or official report of Gilead (2011).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.